EPHB4 and cutaneous mastocytosis: A fourth patient, a teenager with CM-AVM syndrome and a germline variant of EPHB4, was treated with trametinib for high-output cardiac failure secondary to arteriovenous shunting of blood from multiple AVMs in the thigh11.